Microba Life Sciences Limited has enhanced its corporate governance framework, adopting a Code of Conduct, a Whistleblower Policy, and an Anti-Bribery and Corruption Policy, in line with the Australian Securities Exchange (ASX) Corporate Governance Council’s recommendations.
Material actions and disclosures
Microba has implemented several measures to ensure compliance with the ASX Corporate Governance Council’s recommendations. These include:
- A Code of Conduct that applies to all Directors, officers, employees, contractors, consultants, and associates of Microba, available on the company’s website.
- A Whistleblower Policy that encourages employees to report illegal, unacceptable, or undesirable conduct anonymously and confidentially, with procedures for handling disclosures and investigations.
- An Anti-Bribery and Corruption Policy that outlines Microba’s stance on bribes, corruption, and improper payments, with a framework for handling gifts and benefits over $500.
The Board has also established an Audit and Risk Committee to oversee the integrity of Microba’s financial reporting systems and financial statements, and to review the need for an internal audit function.
Microba’s Nomination and Remuneration Committee is responsible for developing and implementing a process for annually evaluating the performance and professional development needs of the Board.
The company’s Board Charter sets out the respective roles and responsibilities of the Board, the Chair, and the Company Secretary, and is available on Microba’s website.
Microba has also adopted a Diversity Policy that promotes diversity and inclusion regardless of employees’ experiences, perspectives, professional skills, gender, gender identity, age, sexual orientation, marital or family status, disabilities, ethnicity, religious beliefs, cultural and socioeconomic backgrounds.
Microba’s Corporate Governance Charters and Policies are available from the company’s website at https://ir.microba.com/corporate-governance/.
Microba’s Corporate Governance Statement was approved by the Board and is current as at 31 August 2026.